Abstract
DREAM/calsenilin/KChIP3 is a calcium binding protein of the neuronal calcium sensor superfamily. DREAM interacts with DRE (downstream regulatory element) sites in the DNA to regulate transcription and with many proteins to exert specialized functions in different subcellular compartments. Work from different laboratories has identified a growing list of interacting proteins that constitutes the DREAM interactome. The knowledge of these interactions has greatly contributed to the understanding of the various physiological functions of DREAM.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Carrion A M, Mellstrom B, Naranjo J R. Protein kinase A-dependent derepression of the human prodynorphin gene via differential binding to an intragenic silencer element. Mol Cell Biol, 1998, 18: 6921–6929, 9819380, 1:CAS:528:DyaK1cXnvVKmtb4%3D
Carrion A M, Link W A, Ledo F, et al. DREAM is a Ca2+-regulated transcriptional repressor. Nature, 1999, 398: 80–84, 10078534, 10.1038/18044, 1:STN:280:DyaK1M7ns1Chsg%3D%3D
An W F, Bowlby M R, Betty M, et al. Modulation of A-type potassium channels by a family of calcium sensors. Nature, 2000, 403: 553–556, 10676964, 10.1038/35000592, 1:CAS:528:DC%2BD3cXht1Witr8%3D
Link W A, Ledo F, Torres B, et al. Day-night changes in downstream regulatory element antagonist modulator/potassium channel interacting protein activity contribute to circadian gene expression in pineal gland. J Neurosci, 2004, 24: 5346–5355, 15190107, 10.1523/JNEUROSCI.1460-04.2004, 1:CAS:528:DC%2BD2cXltFCgur8%3D
Buxbaum J D, Choi E K, Luo Y, et al. Calsenilin: a calcium-binding protein that interacts with the presenilins and regulates the levels of a presenilin fragment. Nat Med, 1998, 4: 1177–1181, 9771752, 10.1038/2673, 1:CAS:528:DyaK1cXms1Ggt70%3D
Mellstrom B, Savignac M, Gomez-Villafuertes R, et al. Ca2+-operated transcriptional networks: molecular mechanisms and in vivo models. Physiol Rev, 2008, 88: 421–449, 18391169, 10.1152/physrev.00041.2005, 1:CAS:528:DC%2BD1cXls1Khs7g%3D
Ledo F, Kremer L, Mellstrom B, et al. Ca2+-dependent block of CREB-CBP transcription by repressor DREAM. EMBO J, 2002, 21: 4583–4592, 12198160, 10.1093/emboj/cdf440, 1:CAS:528:DC%2BD38Xms1Knurk%3D
Wu L J, Mellstrom B, Wang H, et al. DREAM (Downstream Regulatory Element Antagonist Modulator) contributes to synaptic depression and contextual fear memory. Mol Brain, 2010, 3: 3, 20205763, 10.1186/1756-6606-3-3
Rivas M, Mellstrom B, Torres B, et al. The DREAM protein is associated with thyroid enlargement and nodular development. Mol Endocrinol, 2009, 23: 862–870, 19299442, 10.1210/me.2008-0466, 1:CAS:528:DC%2BD1MXntFalur8%3D
Craig T A, Benson L M, Venyaminov S Y, et al. The metal-binding properties of DREAM: evidence for calcium-mediated changes in DREAM structure. J Biol Chem, 2002, 277: 10955–10966, 11788589, 10.1074/jbc.M109660200, 1:CAS:528:DC%2BD38Xis1Khtbs%3D
Osawa M, Tong K I, Lilliehook C, et al. Calcium-regulated DNA binding and oligomerization of the neuronal calcium-sensing protein, calsenilin/DREAM/KChIP3. J Biol Chem, 2001, 276: 41005–41013, 11535596, 10.1074/jbc.M105842200, 1:CAS:528:DC%2BD3MXosVKgs7s%3D
Naranjo J R, Mellstrom B, Achaval M, et al. Molecular pathways of pain: Fos/Jun-mediated activation of a noncanonical AP-1 site in the prodynorphin gene. Neuron, 1991, 6: 607–617, 1901718, 10.1016/0896-6273(91)90063-6, 1:CAS:528:DyaK3MXmt1GjtL8%3D
Wagner J J, Terman G W, Chavkin C. Endogenous dynorphins inhibit excitatory neurotransmission and block LTP induction in the hippocampus. Nature, 1993, 363: 451–454, 8099201, 10.1038/363451a0, 1:CAS:528:DyaK3sXksVWgtro%3D
Ledo F, Carrion A M, Link W A, et al. DREAM-alphaCREM interaction via leucine-charged domains derepresses downstream regulatory element-dependent transcription. Mol Cell Biol, 2000, 20: 9120–9126, 11094064, 10.1128/MCB.20.24.9120-9126.2000, 1:CAS:528:DC%2BD3MXivVamurs%3D
Rivas M, Mellstrom B, Naranjo J R, et al. Transcriptional repressor DREAM interacts with thyroid transcription factor-1 and regulates thyroglobulin gene expression. J Biol Chem, 2004, 279: 33114–33122, 15181011, 10.1074/jbc.M403526200, 1:CAS:528:DC%2BD2cXmtFOisL8%3D
Zaidi N F, Kuplast K G, Washicosky K J, et al. Calsenilin interacts with transcriptional co-repressor C-terminal binding protein(s). J Neurochem, 2006, 98: 1290–1301, 16787403, 10.1111/j.1471-4159.2006.03972.x, 1:CAS:528:DC%2BD28XhtFemu7bL
Leissring M A, Yamasaki T R, Wasco W, et al. Calsenilin reverses presenilin-mediated enhancement of calcium signaling. Proc Natl Acad Sci USA, 2000, 97: 8590–8593, 10900016, 10.1073/pnas.97.15.8590, 1:CAS:528:DC%2BD3cXlt1Gns7o%3D
Lilliehook C, Bozdagi O, Yao J, et al. Altered Abeta formation and long-term potentiation in a calsenilin knock-out. J Neurosci, 2003, 23: 9097–9106, 14534243, 1:CAS:528:DC%2BD3sXotFOms7c%3D
Jo D G, Lee J Y, Hong Y M, et al. Induction of pro-apoptotic calsenilin/DREAM/KChIP3 in Alzheimer’s disease and cultured neurons after amyloid-beta exposure. J Neurochem, 2004, 88: 604–611, 14720210, 10.1111/j.1471-4159.2004.02375.x, 1:CAS:528:DC%2BD2cXhtVaisbg%3D
Jin J K, Choi J K, Wasco W, et al. Expression of calsenilin in neurons and astrocytes in the Alzheimer’s disease brain. Neuroreport, 2005, 16: 451–455, 15770150, 10.1097/00001756-200504040-00007, 1:CAS:528:DC%2BD2MXit1Olsr8%3D
Smith I F, Hitt B, Green K N, et al. Enhanced caffeine-induced Ca2+ release in the 3xTg-AD mouse model of Alzheimer’s disease. J Neurochem, 2005, 94: 1711–1718, 16156741, 10.1111/j.1471-4159.2005.03332.x, 1:CAS:528:DC%2BD2MXhtVaksbvF
Quintero C A, Valdez-Taubas J, Ferrari M L, et al. Calsenilin and CALP interact with the cytoplasmic tail of UDP-Gal:GA2/GM2/GD2 beta-1,3-galactosyltransferase. Biochem J, 2008, 412: 19–26, 18269347, 10.1042/BJ20071725, 1:CAS:528:DC%2BD1cXltVyktb0%3D
Parker D, Ferreri K, Nakajima T, et al. Phosphorylation of CREB at Ser-133 induces complex formation with CREB-binding protein via a direct mechanism. Mol Cell Biol, 1996, 16: 694–703, 8552098, 1:CAS:528:DyaK28XmtVWgsQ%3D%3D
Le Douarin B, Nielsen A L, Garnier J M, et al. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J, 1996, 15: 6701–6715, 8978696
Scsucova S, Palacios D, Savignac M, et al. The repressor DREAM acts as a transcriptional activator on Vitamin D and retinoic acid response elements. Nucleic Acids Res, 2005, 33: 2269–2279, 15849313, 10.1093/nar/gki503, 1:CAS:528:DC%2BD2MXjsl2gsrc%3D
Lusin J D, Vanarotti M, Li C, et al. NMR structure of DREAM: Implications for Ca(2+)-dependent DNA binding and protein dimerization. Biochemistry, 2008, 47: 2252–2264, 18201103, 10.1021/bi7017267, 1:CAS:528:DC%2BD1cXntlKgtw%3D%3D
Iacovelli L, Sallese M, Mariggio S, et al. Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins. FASEB J, 1999, 13: 1–8, 9872924, 1:CAS:528:DyaK1MXlt1ygsA%3D%3D
Ruiz-Gomez A, Mellstrom B, Tornero D, et al. G protein-coupled receptor kinase 2-mediated phosphorylation of downstream regulatory element antagonist modulator regulates membrane trafficking of Kv4.2 potassium channel. J Biol Chem, 2007, 282: 1205–1215, 17102134, 10.1074/jbc.M607166200, 1:CAS:528:DC%2BD2sXit1Kksw%3D%3D
Palczewska M, Casafont I, Ghimire K, et al. Sumoylation regulates nuclear localization of repressor DREAM. Biochim Biophys Acta, 2010, 1813: 1050–1058, 21070824, 10.1016/j.bbamcr.2010.11.001
Rivas M, Aurrekoetxea K, Mellstrom B, et al. Redox signaling regulates transcriptional activity of the Ca(2+)-dependent repressor DREAM. Antioxid Redox Signal, 2010, 14: 1237–1243, 20618065, 10.1089/ars.2010.3385
Zhang Y, Su P, Liang P, et al. The DREAM protein negatively regulates the NMDA receptor through interaction with the NR1 subunit. J Neurosci, 2010, 30: 7575–7586, 20519532, 10.1523/JNEUROSCI.1312-10.2010, 1:CAS:528:DC%2BC3cXovVOit7s%3D
Anderson D, Mehaffey W H, Iftinca M, et al. Regulation of neuronal activity by Cav3-Kv4 channel signaling complexes. Nat Neurosci, 2010, 13: 333–337, 20154682, 10.1038/nn.2493, 1:CAS:528:DC%2BC3cXhvFGmtr0%3D
Thomsen M B, Wang C, Ozgen N, et al. Accessory subunit KChIP2 modulates the cardiac L-type calcium current. Circ Res, 2009, 104: 1382–1389, 19461043, 10.1161/CIRCRESAHA.109.196972, 1:CAS:528:DC%2BD1MXntVymt7w%3D
Rual J F, Venkatesan K, Hao T, et al. Towards a proteome-scale map of the human protein-protein interaction network. Nature, 2005, 437: 1173–1178, 16189514, 10.1038/nature04209, 1:CAS:528:DC%2BD2MXhtFahtLzP
Lin Y L, Wu P F, Wu T T, et al. KChIP3: a binding protein for Taiwan banded krait beta-bungarotoxin. Toxicon, 2006, 47: 265–270, 16356520, 10.1016/j.toxicon.2005.10.020, 1:CAS:528:DC%2BD28XhslKju7k%3D
Burgoyne R D. Neuronal calcium sensor proteins: generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci, 2007, 8: 182–193, 17311005, 10.1038/nrn2093, 1:CAS:528:DC%2BD2sXhvVyqu7g%3D
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published with open access at Springerlink.com
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License (https://creativecommons.org/licenses/by-nc/2.0), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Rivas, M., Villar, D., González, P. et al. Building the DREAM interactome. Sci. China Life Sci. 54, 786–792 (2011). https://doi.org/10.1007/s11427-011-4196-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-011-4196-4